A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 276
- Population
- ALL · 60 Years
- Duration
- 2023-06-05 to 2025-01-23
- Intervention
- lidocaine; Placebo
- Comparator
- Placebo group
- Outcomes measured
- Pain scores of movement-evoked pain at postoperative 24 hours — up to 24 hours postoperatively; Pain scores of movement-evoked pain at postoperative 48 and 72 hours — From the date of the end of surgery until the da…; Pain scores of pain at rest at 24, 48 and 72 hours postoperatively — From the date of the end of surgery until the date…; The incidence of moderate-to-severe movement-evoked pain at 24, 48 and 72 hours postoperatively — From the date of the…; The incidence of moderate-to-severe pain at rest at 24, 48, and 72 hours postoperatively — From the date of the end of…; The cumulative morphine consumption at 24, 48, and 72 hours postoperatively — From the date of the end of surgery until…; Time of Bowel function recovery — At 3 days after surgery; The incidence of postoperative nausea and vomiting during the first 72 hours postoperatively (any nausea or vomiting);…; The incidence of a composite of postoperative pulmonary complications during hospitalisation — during the period from t…; Length of hospital stay — during the period from the end of surgery to discharge, an average of 7 days; Quality of Recovery Scale Score at 24, 48, and 72 hours after surgery — From the date of the end of surgery until the d…; Incidence of lidocaine toxicity — From the time of anesthesia induction until the date of 72 hours postoperatively; plasma lidocaine concentration — From the time of anesthesia induction until the date of 24hours postoperatively
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cancer and ageing · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.